Phase II Study of 96-hr Continuous-Infusion Etoposide and Doxorubicin with Bolus Cyclophosphamide in Refractory Epithelial Ovarian Cancer

Author: Fleming G.F.   Waggoner S.E.   Rotmensch J.   Skoog L.A.   Langhauser C.  

Publisher: Elsevier

ISSN: 0090-8258

Source: Gynecologic Oncology, Vol.65, Iss.1, 1997-04, pp. : 42-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content